{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:07:34Z","timestamp":1782187654309,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clim.2024.110282","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:08:21Z","timestamp":1719209301000},"page":"110282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters"],"prefix":"10.1016","volume":"265","author":[{"given":"Bill","family":"Giannakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Krilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110282_bb0005","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1093\/emboj\/18.22.6228","article-title":"Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome","volume":"18","author":"Schwarzenbacher","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.clim.2024.110282_bb0010","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1074\/jbc.RA120.013939","article-title":"The J-elongated conformation of beta(2)-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome","volume":"295","author":"Ruben","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-0038-1648517","article-title":"Beta 2-glycoprotein I deficiency and the risk of thrombosis","volume":"67","author":"Bancsi","year":"1992","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0020","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"beta(2) -glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0025","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110282_bb0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.110282_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.thromres.2020.10.010","article-title":"Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management","volume":"198","author":"Sayar","year":"2021","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2024.110282_bb0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2006-04-001206","article-title":"Current concepts on the pathogenesis of the antiphospholipid syndrome","volume":"109","author":"Giannakopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.2003.02180.x","article-title":"Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression","volume":"132","author":"Conti","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110282_bb0050","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.V66.5.1086.1086","article-title":"beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway","volume":"66","author":"Schousboe","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0055","article-title":"Beta 2 glycoprotein I and neutrophil extracellular traps: potential bridge between innate and adaptive immunity in anti-phospholipid syndrome","volume":"13","author":"Grossi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110282_bb0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.thromres.2004.07.013","article-title":"Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis","volume":"114","author":"Yasuda","year":"2004","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clim.2024.110282_bb0065","article-title":"Risk of systemic lupus erythematosus in patients with anti-phospholipid syndrome: a population-based study","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"Suppl. 2","key":"10.1016\/j.clim.2024.110282_bb0070","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"72","author":"Rullo","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110282_bb0075","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"\u03b2\u2082-glycoprotein I: a novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing Committee for International Clinical Studies Including Therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110282_bb0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/hematology.2019000073","article-title":"Is there a role for immunosuppression in antiphospholipid syndrome?","volume":"2019","author":"Sevim","year":"2019","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.clim.2024.110282_bb0090","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","article-title":"Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI","volume":"95","author":"Iverson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110282_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12896-015-0222-0","article-title":"Development of a high yield expression and purification system for domain I of Beta-2-glycoprotein I for the treatment of APS","volume":"15","author":"McDonnell","year":"2015","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.clim.2024.110282_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1191\/0961203306lu2270oa","article-title":"Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation","volume":"15","author":"Lin","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2024.110282_bb0105","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2009-03-212910","article-title":"Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men","volume":"114","author":"de Laat","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/acr2.11245","article-title":"Beta-2-glycoprotein-I deficiency could precipitate an antiphospholipid syndrome-like prothrombotic situation in patients with coronavirus disease 2019","volume":"3","author":"Serrano","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.clim.2024.110282_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s13054-020-03066-3","article-title":"Beta-2-glycoprotein I as a biomarker for sepsis in critically ill patients in the intensive care unit: a prospective cohort study","volume":"24","author":"Schrijver","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.clim.2024.110282_bb0120","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1038\/s41598-017-07945-8","article-title":"Beta 2 glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner","volume":"7","author":"El-Assaad","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.110282_bb0125","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1161\/ATVBAHA.120.315156","article-title":"Free thiol beta2-GPI (beta-2-glycoprotein-I) provides a link between inflammation and oxidative stress in atherosclerotic coronary artery disease","volume":"40","author":"Weaver","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2024.110282_bb0130","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.30383","article-title":"Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2glycoprotein I","volume":"63","author":"Ioannou","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110282_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/ars.2014.6052","article-title":"Do Beta 2-glycoprotein I disulfide bonds protect the human retina in the setting of age-related macular degeneration?","volume":"24","author":"Qi","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.clim.2024.110282_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8246839","article-title":"Redox status of beta(2)GPI in different stages of diabetic Angiopathy","volume":"2016","author":"Ma","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clim.2024.110282_bb0145","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M800155-JLR200","article-title":"Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA","volume":"49","author":"Leduc","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clim.2024.110282_bb0150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/ATVBAHA.120.314965","article-title":"Genome-wide association study highlights APOH as a novel locus for lipoprotein(a) Levels-brief report","volume":"41","author":"Hoekstra","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clim.2024.110282_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1538-7836.2008.03223.x","article-title":"Beta2-glycoprotein I is incorrectly named apolipoprotein H","volume":"7","author":"Agar","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102747","article-title":"Beta 2 glycoprotein I exerts antithrombotic function through its domain V in mice","volume":"126","author":"Passam","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110282_bb0165","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1074\/jbc.M010990200","article-title":"Impaired thrombin generation in beta 2-glycoprotein I null mice","volume":"276","author":"Sheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0170","doi-asserted-by":"crossref","first-page":"33656","DOI":"10.1038\/srep33656","article-title":"Gram negative bacterial inflammation ameliorated by the plasma protein Beta 2Glycoprotein I","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2024.110282_bb0175","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/art.38646","article-title":"Deletion of the antiphospholipid syndrome autoantigen beta2 glycoprotein I potentiates the lupus autoimmune phenotype in a toll-like receptor 7-mediated murine model","volume":"66","author":"Giannakopoulos","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2024.110282_bb0180","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.1124978","article-title":"Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication","volume":"312","author":"Pisitkun","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.110282_bb0185","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1073\/pnas.0603912103","article-title":"A Tlr7 translocation accelerates systemic autoimmunity in murine lupus","volume":"103","author":"Subramanian","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110282_bb0190","doi-asserted-by":"crossref","first-page":"92652","DOI":"10.18632\/oncotarget.21536","article-title":"beta2GPI exerts an anti-obesity effect in female mice by inhibiting lipogenesis and promoting lipolysis","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2024.110282_bb0195","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-02-271494","article-title":"Beta 2 glycoprotein I is a substrate of thiol oxidoreductases","volume":"116","author":"Passam","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0200","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1538-7836.2010.03944.x","article-title":"Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1","volume":"8","author":"Passam","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100890","article-title":"An allosteric redox switch in domain V of beta(2)-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition","volume":"297","author":"Kumar","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186513","article-title":"Oxidation of beta2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome","volume":"12","author":"Raimondo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110282_bb0215","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2009-04-215335","article-title":"Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury","volume":"116","author":"Ioannou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0220","article-title":"Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-\u03b21-p38 MAPK pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.clim.2024.110282_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102675","article-title":"Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: implications for thrombosis risk","volume":"122","author":"Krilis","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110282_bb0230","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1073\/pnas.90.6.2141","article-title":"Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity","volume":"90","author":"Hunt","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110282_bb0235","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.str.2009.12.013","article-title":"Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids","volume":"18","author":"Lee","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.clim.2024.110282_bb0240","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1074\/jbc.M110176200","article-title":"Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the 15 consequences of the two biological events in patients with the anti-phospholipid syndrome","volume":"277","author":"Guerin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0245","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood.V91.11.4173","article-title":"Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form","volume":"91","author":"Ohkura","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0250","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/j.1538-7836.2006.02036.x","article-title":"Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family","volume":"4","author":"Pennings","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0255","doi-asserted-by":"crossref","first-page":"36729","DOI":"10.1074\/jbc.M504172200","article-title":"The binding site in {beta}2-glycoprotein I for ApoER2\u2019 on platelets is located in domain V","volume":"280","author":"van Lummel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0260","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1523\/JNEUROSCI.1800-21.2022","article-title":"Human APOER2 isoforms have differential cleavage events and synaptic properties","volume":"42","author":"Omuro","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clim.2024.110282_bb0265","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","article-title":"High\u202f!Ffinity _inding of \u03b22-glycoprotein I to human endothelial cells is mediated by Annexin II*","volume":"275","author":"Ma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"\u03b22-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110282_bb0275","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.4049\/jimmunol.1000526","article-title":"TLR2 is one of the endothelial receptors for beta 2-glycoprotein I","volume":"185","author":"Alard","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110282_bb0280","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1074\/jbc.M704990200","article-title":"Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members","volume":"283","author":"Maiti","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0285","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X20984551","article-title":"\u03b22 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke","volume":"41","author":"Grossi","year":"2021","journal-title":"J. Cerebral Blood Flow Metabol.: Off. J. Intern. Soc. Cerebral Blood Flow Metabol."},{"key":"10.1016\/j.clim.2024.110282_bb0290","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/art.24361","article-title":"Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells","volume":"60","author":"Reed","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110282_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110282_bb0300","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1074\/jbc.M114.619817","article-title":"\u03b22-glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies","volume":"290","author":"Salem","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/art.22367","article-title":"Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation","volume":"56","author":"Rahgozar","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2024.110282_bb0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0400281101","article-title":"Beta 2-glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I","volume":"101","author":"Shi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.clim.2024.110282_bb0315","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/jbc.M410291200","article-title":"Domain V of beta2-glycoprotein I binds factor XI\/XIa and is cleaved at Lys317Thr318","volume":"280","author":"Shi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2024.110282_bb0320","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0304-4165(86)90237-0","article-title":"Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I","volume":"884","author":"Nimpf","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2024.110282_bb0325","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1042\/BCJ20160603","article-title":"Molecular mapping of \u03b1-thrombin (\u03b1T)\/\u03b22-glycoprotein I (\u03b22\u2019pI) interaction reveals how \u03b22\u2019pI affects \u03b1T functions","volume":"473","author":"Acquasaliente","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2024.110282_bb0330","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2353\/ajpath.2007.070146","article-title":"Plasmin-cleaved beta-2glycoprotein 1 is an inhibitor of angiogenesis","volume":"171","author":"Sakai","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2024.110282_bb0335","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood-2008-12-190629","article-title":"Nicked beta2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property","volume":"114","author":"Nakagawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0340","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1245\/s10434-006-9009-9","article-title":"An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I","volume":"13","author":"Beecken","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.clim.2024.110282_bb0345","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2010.04.010","article-title":"Plasmin-clipped beta(2)-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27","volume":"296","author":"Beecken","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.clim.2024.110282_bb0350","first-page":"13","article-title":"The function of \u03b22-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts","volume":"70","author":"Wahyuningsih","year":"2016","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.clim.2024.110282_bb0355","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1538-7836.2008.03000.x","article-title":"Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain","volume":"6","author":"Yu","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clim.2024.110282_bb0360","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.berh.2019.01.007","article-title":"Mutants of \u03b22-glycoprotein I: their features and potent applications","volume":"32","author":"Shen","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.clim.2024.110282_bb0365","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2010.06.013","article-title":"In vivo modulation of angiogenesis by beta 2 glycoprotein I","volume":"35","author":"Passam","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110282_bb0370","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2003-08-2712","article-title":"Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis","volume":"103","author":"Yasuda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0375","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","article-title":"\u03b2\u2082-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"Gropp","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0380","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.2000570","article-title":"Complement\u202f Activation and Thrombin Generation by MBL bound to \u03b22Glycoprotein I","volume":"205","author":"Durigutto","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110282_bb0385","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2022.03.005","article-title":"Intertwined pathways of complement activation command the pathogenesis of lupus nephritis","volume":"245","author":"Satyam","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.clim.2024.110282_bb0390","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10495-005-0817-3","article-title":"Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis","volume":"10","author":"Balasubramanian","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.clim.2024.110282_bb0395","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Agar","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1191\/0961203303lu280oa","article-title":"Anti-beta2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding","volume":"12","author":"Reddel","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2024.110282_bb0405","article-title":"Animal models of venous thrombosis","volume":"S197-S206","author":"Albadawi","year":"2017","journal-title":"Cardiovasc. Diagnosis Therapy"},{"key":"10.1016\/j.clim.2024.110282_bb0410","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110282_bb0415","article-title":"The fifth domain of Beta 2 glycoprotein I protects from natural IgM mediated cardiac Ischaemia reperfusion injury","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110282_bb0420","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.4049\/jimmunol.1002520","article-title":"Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia\/reperfusion-induced tissue damage and inflammation","volume":"185","author":"Fleming","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110282_bb0425","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100561118","article-title":"DNAse-dependent, NET-independent pathway of thrombus formation in vivo","volume":"118","author":"Carminita","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624003917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:54:20Z","timestamp":1731603260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624003917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":85,"alternative-id":["S1521661624003917"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110282","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110282"}}